Carbon-11 HOMADAM: A novel PET radiotracer for imaging serotonin transporters

Nachwa Jarkas, John R. Votaw, Ronald J. Voll, Larry Williams, Vernon M. Camp, Michael J. Owens, David C. Purselle, J. Douglas Bremner, Clinton D. Kilts, Charles Nemeroff, Mark M. Goodman

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Carbon-11-labeled N,N-dimethyl-2-(2′-amino-4′- hydroxymethylphenylthio)benzylamine (HOMADAM) was synthesized as a new serotonin transporter (SERT) imaging agent. Methods: Carbon-11 was introduced into HOMADAM by preparation of N-methyl-2-(2′-amino-4′- hydroxymethylphenylthio)benzylamine followed by alkylation with carbon-11 iodomethane. Binding affinities of HOMADAM and the radiolabeling substrate, N-methyl-2-(2′-amino-4′-hydroxymethylphenylthio)benzylamine, were determined in cDNA transfected cells expressing human SERT, dopamine transporters (DAT) and norepinephrine transporters NET using [ 3H]citalopram, [125I]RTI-55 and [3H]nisoxetine, respectively. MicroPET brain imaging was performed in monkeys. Arterial plasma metabolites of HOMADAM were analyzed in a rhesus monkey by high-performance liquid chromatography (HPLC). Results: HOMADAM displayed high affinity for the SERT (Ki=0.6 nM). N-methyl-2-(2′-amino-4′- hydroxymethylphenylthio)benzylamine displayed moderate affinity for the SERT (Ki=15.11 nM). The affinities of HOMADAM for the DAT and NET were 2000- and 253-fold lower, respectively, than for the SERT. [11C] HOMADAM was prepared from [11C]iodomethane in approximately 25% radiochemical yield (decay-corrected to end of bombardment). MicroPET brain imaging studies in monkeys demonstrated that [11C]HOMADAM uptake was selectively localized in the midbrain, thalamus, pons, caudate, putamen and medulla. The midbrain-to-cerebellum, pons-to-cerebellum, thalamus-to-cerebellum and putamen-to-cerebellum ratios at 85 min were 4.2, 2.8, 2.3 and 2.0, respectively. HOMADAM binding achieved quasi-equilibrium at 45 min. Radioactivity in the SERT-rich regions of monkey brain was displaceable with R,S-citalopram. Radioactivity in the DAT-rich regions of monkey brain was not displaceable with the DAT ligand RTI-113. Radioactivity in the SERT-rich regions of monkey brain was displaceable with the R,S-reboxetine, a NET ligand with a high nanomolar affinity for SERT. Arterial plasma metabolites of HOMADAM were analyzed in a rhesus monkey by HPLC and displayed a single peak that corresponded to unmetabolized HOMADAM. Conclusion: HOMADAM is an excellent candidate for PET primate imaging of brain SERTs.

Original languageEnglish
Pages (from-to)211-224
Number of pages14
JournalNuclear Medicine and Biology
Volume32
Issue number3
DOIs
StatePublished - Apr 1 2005
Externally publishedYes

Fingerprint

Serotonin Plasma Membrane Transport Proteins
Dopamine Plasma Membrane Transport Proteins
Haplorhini
Cerebellum
Neuroimaging
Radioactivity
Citalopram
nisoxetine
Carbon
Pons
Putamen
Mesencephalon
Macaca mulatta
Thalamus
Brain
High Pressure Liquid Chromatography
Norepinephrine Plasma Membrane Transport Proteins
Ligands
N,N-dimethyl-2-(2'-amino-4'-hydroxymethylphenylthio)benzylamine
Alkylation

Keywords

  • Carbon-11
  • HOMADAM
  • MicroPET
  • N, N-dimethylbenzylamine
  • Serotonin transporter

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

Jarkas, N., Votaw, J. R., Voll, R. J., Williams, L., Camp, V. M., Owens, M. J., ... Goodman, M. M. (2005). Carbon-11 HOMADAM: A novel PET radiotracer for imaging serotonin transporters. Nuclear Medicine and Biology, 32(3), 211-224. https://doi.org/10.1016/j.nucmedbio.2004.11.007

Carbon-11 HOMADAM : A novel PET radiotracer for imaging serotonin transporters. / Jarkas, Nachwa; Votaw, John R.; Voll, Ronald J.; Williams, Larry; Camp, Vernon M.; Owens, Michael J.; Purselle, David C.; Bremner, J. Douglas; Kilts, Clinton D.; Nemeroff, Charles; Goodman, Mark M.

In: Nuclear Medicine and Biology, Vol. 32, No. 3, 01.04.2005, p. 211-224.

Research output: Contribution to journalArticle

Jarkas, N, Votaw, JR, Voll, RJ, Williams, L, Camp, VM, Owens, MJ, Purselle, DC, Bremner, JD, Kilts, CD, Nemeroff, C & Goodman, MM 2005, 'Carbon-11 HOMADAM: A novel PET radiotracer for imaging serotonin transporters', Nuclear Medicine and Biology, vol. 32, no. 3, pp. 211-224. https://doi.org/10.1016/j.nucmedbio.2004.11.007
Jarkas, Nachwa ; Votaw, John R. ; Voll, Ronald J. ; Williams, Larry ; Camp, Vernon M. ; Owens, Michael J. ; Purselle, David C. ; Bremner, J. Douglas ; Kilts, Clinton D. ; Nemeroff, Charles ; Goodman, Mark M. / Carbon-11 HOMADAM : A novel PET radiotracer for imaging serotonin transporters. In: Nuclear Medicine and Biology. 2005 ; Vol. 32, No. 3. pp. 211-224.
@article{e4652e319acd4f2cb7cc67909851aa57,
title = "Carbon-11 HOMADAM: A novel PET radiotracer for imaging serotonin transporters",
abstract = "Carbon-11-labeled N,N-dimethyl-2-(2′-amino-4′- hydroxymethylphenylthio)benzylamine (HOMADAM) was synthesized as a new serotonin transporter (SERT) imaging agent. Methods: Carbon-11 was introduced into HOMADAM by preparation of N-methyl-2-(2′-amino-4′- hydroxymethylphenylthio)benzylamine followed by alkylation with carbon-11 iodomethane. Binding affinities of HOMADAM and the radiolabeling substrate, N-methyl-2-(2′-amino-4′-hydroxymethylphenylthio)benzylamine, were determined in cDNA transfected cells expressing human SERT, dopamine transporters (DAT) and norepinephrine transporters NET using [ 3H]citalopram, [125I]RTI-55 and [3H]nisoxetine, respectively. MicroPET brain imaging was performed in monkeys. Arterial plasma metabolites of HOMADAM were analyzed in a rhesus monkey by high-performance liquid chromatography (HPLC). Results: HOMADAM displayed high affinity for the SERT (Ki=0.6 nM). N-methyl-2-(2′-amino-4′- hydroxymethylphenylthio)benzylamine displayed moderate affinity for the SERT (Ki=15.11 nM). The affinities of HOMADAM for the DAT and NET were 2000- and 253-fold lower, respectively, than for the SERT. [11C] HOMADAM was prepared from [11C]iodomethane in approximately 25{\%} radiochemical yield (decay-corrected to end of bombardment). MicroPET brain imaging studies in monkeys demonstrated that [11C]HOMADAM uptake was selectively localized in the midbrain, thalamus, pons, caudate, putamen and medulla. The midbrain-to-cerebellum, pons-to-cerebellum, thalamus-to-cerebellum and putamen-to-cerebellum ratios at 85 min were 4.2, 2.8, 2.3 and 2.0, respectively. HOMADAM binding achieved quasi-equilibrium at 45 min. Radioactivity in the SERT-rich regions of monkey brain was displaceable with R,S-citalopram. Radioactivity in the DAT-rich regions of monkey brain was not displaceable with the DAT ligand RTI-113. Radioactivity in the SERT-rich regions of monkey brain was displaceable with the R,S-reboxetine, a NET ligand with a high nanomolar affinity for SERT. Arterial plasma metabolites of HOMADAM were analyzed in a rhesus monkey by HPLC and displayed a single peak that corresponded to unmetabolized HOMADAM. Conclusion: HOMADAM is an excellent candidate for PET primate imaging of brain SERTs.",
keywords = "Carbon-11, HOMADAM, MicroPET, N, N-dimethylbenzylamine, Serotonin transporter",
author = "Nachwa Jarkas and Votaw, {John R.} and Voll, {Ronald J.} and Larry Williams and Camp, {Vernon M.} and Owens, {Michael J.} and Purselle, {David C.} and Bremner, {J. Douglas} and Kilts, {Clinton D.} and Charles Nemeroff and Goodman, {Mark M.}",
year = "2005",
month = "4",
day = "1",
doi = "10.1016/j.nucmedbio.2004.11.007",
language = "English",
volume = "32",
pages = "211--224",
journal = "Nuclear Medicine and Biology",
issn = "0969-8051",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Carbon-11 HOMADAM

T2 - A novel PET radiotracer for imaging serotonin transporters

AU - Jarkas, Nachwa

AU - Votaw, John R.

AU - Voll, Ronald J.

AU - Williams, Larry

AU - Camp, Vernon M.

AU - Owens, Michael J.

AU - Purselle, David C.

AU - Bremner, J. Douglas

AU - Kilts, Clinton D.

AU - Nemeroff, Charles

AU - Goodman, Mark M.

PY - 2005/4/1

Y1 - 2005/4/1

N2 - Carbon-11-labeled N,N-dimethyl-2-(2′-amino-4′- hydroxymethylphenylthio)benzylamine (HOMADAM) was synthesized as a new serotonin transporter (SERT) imaging agent. Methods: Carbon-11 was introduced into HOMADAM by preparation of N-methyl-2-(2′-amino-4′- hydroxymethylphenylthio)benzylamine followed by alkylation with carbon-11 iodomethane. Binding affinities of HOMADAM and the radiolabeling substrate, N-methyl-2-(2′-amino-4′-hydroxymethylphenylthio)benzylamine, were determined in cDNA transfected cells expressing human SERT, dopamine transporters (DAT) and norepinephrine transporters NET using [ 3H]citalopram, [125I]RTI-55 and [3H]nisoxetine, respectively. MicroPET brain imaging was performed in monkeys. Arterial plasma metabolites of HOMADAM were analyzed in a rhesus monkey by high-performance liquid chromatography (HPLC). Results: HOMADAM displayed high affinity for the SERT (Ki=0.6 nM). N-methyl-2-(2′-amino-4′- hydroxymethylphenylthio)benzylamine displayed moderate affinity for the SERT (Ki=15.11 nM). The affinities of HOMADAM for the DAT and NET were 2000- and 253-fold lower, respectively, than for the SERT. [11C] HOMADAM was prepared from [11C]iodomethane in approximately 25% radiochemical yield (decay-corrected to end of bombardment). MicroPET brain imaging studies in monkeys demonstrated that [11C]HOMADAM uptake was selectively localized in the midbrain, thalamus, pons, caudate, putamen and medulla. The midbrain-to-cerebellum, pons-to-cerebellum, thalamus-to-cerebellum and putamen-to-cerebellum ratios at 85 min were 4.2, 2.8, 2.3 and 2.0, respectively. HOMADAM binding achieved quasi-equilibrium at 45 min. Radioactivity in the SERT-rich regions of monkey brain was displaceable with R,S-citalopram. Radioactivity in the DAT-rich regions of monkey brain was not displaceable with the DAT ligand RTI-113. Radioactivity in the SERT-rich regions of monkey brain was displaceable with the R,S-reboxetine, a NET ligand with a high nanomolar affinity for SERT. Arterial plasma metabolites of HOMADAM were analyzed in a rhesus monkey by HPLC and displayed a single peak that corresponded to unmetabolized HOMADAM. Conclusion: HOMADAM is an excellent candidate for PET primate imaging of brain SERTs.

AB - Carbon-11-labeled N,N-dimethyl-2-(2′-amino-4′- hydroxymethylphenylthio)benzylamine (HOMADAM) was synthesized as a new serotonin transporter (SERT) imaging agent. Methods: Carbon-11 was introduced into HOMADAM by preparation of N-methyl-2-(2′-amino-4′- hydroxymethylphenylthio)benzylamine followed by alkylation with carbon-11 iodomethane. Binding affinities of HOMADAM and the radiolabeling substrate, N-methyl-2-(2′-amino-4′-hydroxymethylphenylthio)benzylamine, were determined in cDNA transfected cells expressing human SERT, dopamine transporters (DAT) and norepinephrine transporters NET using [ 3H]citalopram, [125I]RTI-55 and [3H]nisoxetine, respectively. MicroPET brain imaging was performed in monkeys. Arterial plasma metabolites of HOMADAM were analyzed in a rhesus monkey by high-performance liquid chromatography (HPLC). Results: HOMADAM displayed high affinity for the SERT (Ki=0.6 nM). N-methyl-2-(2′-amino-4′- hydroxymethylphenylthio)benzylamine displayed moderate affinity for the SERT (Ki=15.11 nM). The affinities of HOMADAM for the DAT and NET were 2000- and 253-fold lower, respectively, than for the SERT. [11C] HOMADAM was prepared from [11C]iodomethane in approximately 25% radiochemical yield (decay-corrected to end of bombardment). MicroPET brain imaging studies in monkeys demonstrated that [11C]HOMADAM uptake was selectively localized in the midbrain, thalamus, pons, caudate, putamen and medulla. The midbrain-to-cerebellum, pons-to-cerebellum, thalamus-to-cerebellum and putamen-to-cerebellum ratios at 85 min were 4.2, 2.8, 2.3 and 2.0, respectively. HOMADAM binding achieved quasi-equilibrium at 45 min. Radioactivity in the SERT-rich regions of monkey brain was displaceable with R,S-citalopram. Radioactivity in the DAT-rich regions of monkey brain was not displaceable with the DAT ligand RTI-113. Radioactivity in the SERT-rich regions of monkey brain was displaceable with the R,S-reboxetine, a NET ligand with a high nanomolar affinity for SERT. Arterial plasma metabolites of HOMADAM were analyzed in a rhesus monkey by HPLC and displayed a single peak that corresponded to unmetabolized HOMADAM. Conclusion: HOMADAM is an excellent candidate for PET primate imaging of brain SERTs.

KW - Carbon-11

KW - HOMADAM

KW - MicroPET

KW - N, N-dimethylbenzylamine

KW - Serotonin transporter

UR - http://www.scopus.com/inward/record.url?scp=20144388151&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20144388151&partnerID=8YFLogxK

U2 - 10.1016/j.nucmedbio.2004.11.007

DO - 10.1016/j.nucmedbio.2004.11.007

M3 - Article

C2 - 15820756

AN - SCOPUS:20144388151

VL - 32

SP - 211

EP - 224

JO - Nuclear Medicine and Biology

JF - Nuclear Medicine and Biology

SN - 0969-8051

IS - 3

ER -